1 in 3 people in the UK living with #Dementia are not diagnosed, yet 91% of those affected by it say there are benefits to getting a diagnosis.

Let’s raise awareness and make sure patients get the care they need & deserve. 💙

#Dementia ActionWeek @‌alzheimerssoc #Neurology

#Dementia ActionWeek 💙
The underdiagnosis of #Dementia & #Alzheimers in the UK must be addressed.

Could a blood-based biomarker assessment for #Alzheimers help with this, and is the test feasible?

Hear from Dr Heslegrave (Dr Amanda):
👉 ow.ly/t62350RBSNy

@‌alzheimerssoc

A dementia diagnosis is vital to ensure patients receive the care they need. 🏥

Watch our interview with Panos Alexopoulos, who discusses the facilitation of dementia diagnosis across the world 🌎:
👉 ow.ly/miUZ50RBSEc

#DementiaActionWeek @‌alzheimerssoc #NeuroTwitter

Do you have an experience with #Dementia diagnosis? 🧠

This #Dementia ActionWeek, visit ow.ly/Km8I50RBAO2 to share your story and show decision-makers the realities & challenges of getting a diagnosis.

@‌alzheimerssoc #NeuroTwitter #Neurology

As Prof. Dorota Religa highlights, recent studies emphasize the importance of a ‘timely diagnosis’ for patients with #Dementia :
👉 ow.ly/IRFe50RBAAH

This #Dementia ActionWeek, we must call on the government & NHS to prioritize dementia diagnosis!🧠

@‌alzheimerssoc

A third of patients in the UK with #Dementia do not have a diagnosis.❗

What does the future of diagnosis look like & will advances help to improve diagnosis rates? 💭

Hear from Lyduine Collij: 👉 ow.ly/AyjM50RBwm0

@‌alzheimerssoc #Dementia ActionWeek #Alzheimers

This week is #Dementia ActionWeek ! 🧠

The focus this year is on the diagnosis of dementia.

Together, let’s call on the Government and the NHS to prioritize dementia in policy and decision-making! 🤝

@‌alzheimerssoc #NeuroTwitter #Dementia #Neurology

Urs Martin Fischer has provided an initial insight into the findings of the SWITCH Trial. 'To SWITCH, or not to SWITCH, that is the question.' We can't wait to hear more at #ESOC2024 .
👉ow.ly/j2uG50Ryb2u
#stroke #stroke twitter #voiceofstroke UniSpitalBaselCH SWITCH Trial

Revisiting BACE inhibitors: the potential of BACE1 for delaying #Alzheimers onset

Robert Vassar (Northwestern Feinberg School of Medicine) talks on reconsidering BACE inhibitors’ potential in AD, to find an effect dose while avoiding cognitive side effects: tinyurl.com/yeyruabh

If you are interested in using cerebrospinal fluid (CSF) biomarkers in your research, clinical practice or trials, consider to read our recent Nature Communications paper!
Big thanks to Linda Karlsson for spearheading the project so professionally!

Join Michael Weiner, M.D. (UC San Francisco, @ncireveterans, VA San Francisco) for his #AAIC24 presentation, “ADNI: Two Decades of Impact and the Path Forward” on Thursday, August 1! Read more about the largest and most influential meeting in dementia science and register: alz.org/aaic24

Perfect way to celebrate International Women's Day - hearing from top scientists leading the charge in #Alzheimers research at #ADPD2024

Thank you to all the women in STEM who share their work with us, driving progress & empowering others 🙌🧠🤩

#InternationalWomensDay

Today is International Women's Day and we are joining the campaign to #InspireInclusion 💜

We'd like to thank all of the incredible women within this field, who work hard to make a difference 👩‍⚕️🧠🩺

#IWD2024

It was a pleasure to chat with Prof. Melissa E. Murray 📸🔬 today at #ADPD2024
Discussing the important topic of young onset #Alzheimers & the notable corticolimbic vulnerability in these patients

Dr Murray is developing a corticolimbic index to quantitatively assess heterogeneity & deeply

Great talk from Jeff Cummings at #ADPD2024 although sadly the news isn’t what we would like to hear… good news, bad news, bad news… with fewer #dementia trials taking place now than a year ago

The day continues with lots of parallel sessions at #ADPD2024 . 👏🏻 Here are some key takeaways from “Tau mechanisms 02”:

✨Don’t forget to visit the posters area and learn more about your peers’ research! #ADPD2024 #neuroscience

Happy to be at #ADPD2024 , hearing from experts at the forefront of #Alzheimers research

We spoke with Jenna Najar, MD PhD of Sahlgrenska Universitetssjukhuset Amsterdam UMC about her work looking at the role of genetics in the overlap between dementia & neuropsychiatric disorders 🔜 VJNeurology.com

📸 7-Tesla MRI in the study of aging & neurodegenerative disease

Tamer Ibrahim of Swanson School of Engineering speaks on 7T MRI & the work of his lab to develop new technologies with improved image quality, extended imaging coverage, & anti-claustrophobia solutions:
ow.ly/1gAm50QzFeR

🗓️ #RareDiseaseDay is on Feb 29 this year—the rarest day of the year!

Join VJ Neurology in standing with the rare disease community. Together, let's raise awareness and support for those facing unique challenges 💙🌐

Use #RareDiseaseDay to join the campaign!

Rare Disease Day